{"transactions":[{"id":1519598,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-05-13T21:47:18.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":229,"price":86.72,"value":19858.88,"ownership":{"direct":true},"balance_after":17081.198,"source":{"system":"sec-edgar","filing":"0001225208-24-005986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005986/doc4.xml","form_type":"4"}},{"id":1522378,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:38:00.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":4820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":4820,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":4820},"source":{"system":"sec-edgar","filing":"0001225208-24-005884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005884/doc4.xml","form_type":"4"}},{"id":1522377,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-05-09T23:38:00.000Z","date":"2024-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":178,"price":85.09,"value":15146.02,"ownership":{"direct":true},"balance_after":17310.198,"source":{"system":"sec-edgar","filing":"0001225208-24-005884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005884/doc4.xml","form_type":"4"}},{"id":1522376,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-05-09T23:38:00.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":2445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":17488.198,"source":{"system":"sec-edgar","filing":"0001225208-24-005884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005884/doc4.xml","form_type":"4"}},{"id":1526678,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:15.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":120,"price":85.25,"value":10230.0,"ownership":{"direct":true},"balance_after":15043.198,"source":{"system":"sec-edgar","filing":"0001225208-24-005705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005705/doc4.xml","form_type":"4"}},{"id":1526677,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:15.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":106,"price":85.06,"value":9016.36,"ownership":{"direct":true},"balance_after":15163.198,"source":{"system":"sec-edgar","filing":"0001225208-24-005705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005705/doc4.xml","form_type":"4"}},{"id":1623351,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-02-23T23:51:23.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":1998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on February 22, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":15085.1838,"source":{"system":"sec-edgar","filing":"0001225208-24-002857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824002857/doc4.xml","form_type":"4"}},{"id":1650026,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-02-12T22:44:54.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":12210,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":12210},"source":{"system":"sec-edgar","filing":"0001225208-24-001867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001867/doc4.xml","form_type":"4"}},{"id":1650025,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-02-12T22:44:54.000Z","date":"2024-02-12","kind":"sale","planned":false,"acquired":false,"shares":12210,"price":87,"value":1062270.0,"ownership":{"direct":true},"balance_after":13087.1838,"source":{"system":"sec-edgar","filing":"0001225208-24-001867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001867/doc4.xml","form_type":"4"}},{"id":1650024,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-02-12T22:44:54.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":12210,"price":36.75,"value":448717.5,"ownership":{"direct":true},"balance_after":25297.1838,"source":{"system":"sec-edgar","filing":"0001225208-24-001867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001867/doc4.xml","form_type":"4"}},{"id":1894044,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-05-15T22:28:03.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":5540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":5540,"derivative":{"exercise_price":88.78,"exercise_date":"2024-05-11","expiration_date":"2030-05-10","underlying":"Common Stock","underlying_shares":5540},"source":{"system":"sec-edgar","filing":"0001225208-23-005920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005920/doc4.xml","form_type":"4"}},{"id":1894043,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-05-15T22:28:03.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":13035.7904,"source":{"system":"sec-edgar","filing":"0001225208-23-005920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005920/doc4.xml","form_type":"4"}},{"id":1899927,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-05-09T23:50:12.000Z","date":"2023-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":161,"price":88.74,"value":14287.14,"ownership":{"direct":true},"balance_after":11235.7904,"source":{"system":"sec-edgar","filing":"0001225208-23-005621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005621/doc4.xml","form_type":"4"}},{"id":1899926,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-05-09T23:50:12.000Z","date":"2023-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":134,"price":88.74,"value":11891.16,"ownership":{"direct":true},"balance_after":11396.7904,"source":{"system":"sec-edgar","filing":"0001225208-23-005621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005621/doc4.xml","form_type":"4"}},{"id":1904793,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-05-05T01:48:43.000Z","date":"2023-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":116,"price":88.1,"value":10219.6,"ownership":{"direct":true},"balance_after":11530.7904,"source":{"system":"sec-edgar","filing":"0001225208-23-005432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005432/doc4.xml","form_type":"4"}},{"id":1904792,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-05-05T01:48:43.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":103,"price":87.81,"value":9044.43,"ownership":{"direct":true},"balance_after":11646.7904,"source":{"system":"sec-edgar","filing":"0001225208-23-005432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005432/doc4.xml","form_type":"4"}},{"id":1911615,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-04-28T23:08:08.000Z","date":"2023-04-28","kind":"exercise","planned":false,"acquired":false,"shares":12270,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.1967,"exercise_date":"2017-05-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":12270},"source":{"system":"sec-edgar","filing":"0001225208-23-005181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005181/doc4.xml","form_type":"4"}},{"id":1911614,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-04-28T23:08:08.000Z","date":"2023-04-28","kind":"sale","planned":false,"acquired":false,"shares":12270,"price":87.2,"value":1069944.0,"ownership":{"direct":true},"balance_after":11749.7904,"source":{"system":"sec-edgar","filing":"0001225208-23-005181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005181/doc4.xml","form_type":"4"}},{"id":1911613,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-04-28T23:08:08.000Z","date":"2023-04-28","kind":"exercise","planned":false,"acquired":true,"shares":12270,"price":35.1967,"value":431863.509,"ownership":{"direct":true},"balance_after":24019.7904,"source":{"system":"sec-edgar","filing":"0001225208-23-005181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005181/doc4.xml","form_type":"4"}},{"id":2268868,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2022-05-18T01:16:09.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":211,"price":95.93,"value":20241.23,"ownership":{"direct":true},"balance_after":11436.4609,"source":{"system":"sec-edgar","filing":"0001225208-22-007137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007137/doc4.xml","form_type":"4"}},{"id":2276579,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2022-05-11T00:52:10.000Z","date":"2022-05-08","kind":"tax_withholding","acquired":false,"shares":155,"price":100.52,"value":15580.6,"ownership":{"direct":true},"balance_after":11647.4609,"source":{"system":"sec-edgar","filing":"0001225208-22-006810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006810/doc4.xml","form_type":"4"}},{"id":2276578,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2022-05-11T00:52:10.000Z","date":"2022-05-07","kind":"tax_withholding","acquired":false,"shares":134,"price":100.52,"value":13469.68,"ownership":{"direct":true},"balance_after":11802.4609,"source":{"system":"sec-edgar","filing":"0001225208-22-006810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006810/doc4.xml","form_type":"4"}},{"id":2281161,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-05-05T21:51:36.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":3480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":3480,"derivative":{"exercise_price":105.93,"exercise_date":"2023-05-03","expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":3480},"source":{"system":"sec-edgar","filing":"0001225208-22-006583","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006583/doc4.xml","form_type":"4"}},{"id":2281160,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2022-05-05T21:51:36.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":116,"price":105.93,"value":12287.88,"ownership":{"direct":true},"balance_after":11936.4609,"source":{"system":"sec-edgar","filing":"0001225208-22-006583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006583/doc4.xml","form_type":"4"}},{"id":2281159,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2022-05-05T21:51:36.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":1180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":12052.4609,"source":{"system":"sec-edgar","filing":"0001225208-22-006583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006583/doc4.xml","form_type":"4"}},{"id":2706194,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2021-05-19T20:31:10.000Z","date":"2021-05-17","kind":"tax_withholding","acquired":false,"shares":204,"price":89.49,"value":18255.96,"ownership":{"direct":true},"balance_after":10555.6925,"source":{"system":"sec-edgar","filing":"0001225208-21-008304","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008304/doc4.xml","form_type":"4"}},{"id":2717069,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2021-05-13T01:38:27.000Z","date":"2021-05-11","kind":"tax_withholding","acquired":false,"shares":274,"price":90.4,"value":24769.6,"ownership":{"direct":true},"balance_after":10759.6925,"source":{"system":"sec-edgar","filing":"0001225208-21-008060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008060/doc4.xml","form_type":"4"}},{"id":2719255,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2021-05-11T21:14:27.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":133,"price":91.75,"value":12202.75,"ownership":{"direct":true},"balance_after":11033.6925,"source":{"system":"sec-edgar","filing":"0001225208-21-007971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007971/doc4.xml","form_type":"4"}},{"id":2725473,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-05-07T01:12:45.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":4250,"derivative":{"exercise_price":93.31,"exercise_date":"2022-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001225208-21-007712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007712/doc4.xml","form_type":"4"}},{"id":2725472,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2021-05-07T01:12:45.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":1340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":11166.6925,"source":{"system":"sec-edgar","filing":"0001225208-21-007712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007712/doc4.xml","form_type":"4"}},{"id":2741163,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2021-04-24T01:26:45.000Z","date":"2021-04-23","kind":"sale","acquired":false,"shares":12000,"price":97.6647,"value":1171976.4,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $97.6600 to $97.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20409,"source":{"system":"sec-edgar","filing":"0001225208-21-006982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821006982/doc4.xml","form_type":"4"}},{"id":2864267,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2021-02-13T01:39:10.000Z","date":"2020-12-10","kind":"gift","acquired":true,"shares":32409,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":32409,"source":{"system":"sec-edgar","filing":"0001225208-21-002471","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821002471/doc5.xml","form_type":"5"}},{"id":2864266,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2021-02-13T01:39:10.000Z","date":"2020-12-10","kind":"gift","acquired":false,"shares":32409,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9642.1372,"source":{"system":"sec-edgar","filing":"0001225208-21-002471","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821002471/doc5.xml","form_type":"5"}},{"id":3045775,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-08-27T22:14:25.000Z","date":"2020-08-27","kind":"exercise","acquired":false,"shares":21540,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":21.76,"exercise_date":"2016-05-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":21540},"source":{"system":"sec-edgar","filing":"0001225208-20-011069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820011069/doc4.xml","form_type":"4"}},{"id":3045774,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-08-27T22:14:25.000Z","date":"2020-08-27","kind":"sale","acquired":false,"shares":21540,"price":82.598,"value":1779160.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $82.5300 to $82.7900.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":42040.1239,"source":{"system":"sec-edgar","filing":"0001225208-20-011069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820011069/doc4.xml","form_type":"4"}},{"id":3045773,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-08-27T22:14:25.000Z","date":"2020-08-27","kind":"exercise","acquired":true,"shares":21540,"price":21.76,"value":468710.4,"ownership":{"direct":true},"balance_after":63580.1239,"source":{"system":"sec-edgar","filing":"0001225208-20-011069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820011069/doc4.xml","form_type":"4"}},{"id":3151361,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-05-13T20:15:02.000Z","date":"2020-05-12","kind":"tax_withholding","acquired":false,"shares":88,"price":225.05,"value":19804.4,"ownership":{"direct":true},"balance_after":13941.7761,"source":{"system":"sec-edgar","filing":"0001225208-20-007575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007575/doc4.xml","form_type":"4"}},{"id":3151360,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-05-13T20:15:02.000Z","date":"2020-05-11","kind":"tax_withholding","acquired":false,"shares":88,"price":217.84,"value":19169.92,"ownership":{"direct":true},"balance_after":14029.7761,"source":{"system":"sec-edgar","filing":"0001225208-20-007575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007575/doc4.xml","form_type":"4"}},{"id":3156938,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-05-09T01:51:13.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2020 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":1700,"derivative":{"exercise_price":218.04,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001225208-20-007344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007344/doc4.xml","form_type":"4"}},{"id":3156937,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-05-09T01:51:13.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2020 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":14117.7761,"source":{"system":"sec-edgar","filing":"0001225208-20-007344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007344/doc4.xml","form_type":"4"}},{"id":3455481,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2019-07-27T00:03:54.000Z","date":"2019-07-25","kind":"exercise","acquired":false,"shares":7297,"price":211.5715,"value":1543837.2355,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.785,"exercise_date":"2014-05-14","expiration_date":"2020-05-13","underlying":"Common Stock","underlying_shares":7297},"source":{"system":"sec-edgar","filing":"0001225208-19-010542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819010542/doc4.xml","form_type":"4"}},{"id":3455480,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2019-07-27T00:03:54.000Z","date":"2019-07-25","kind":"exercise","acquired":false,"shares":10120,"price":211.5715,"value":2141103.58,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":41.94,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":10120},"source":{"system":"sec-edgar","filing":"0001225208-19-010542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819010542/doc4.xml","form_type":"4"}},{"id":3455479,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-07-27T00:03:54.000Z","date":"2019-07-25","kind":"sale","acquired":false,"shares":4992,"price":211.4097,"value":1055357.2224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $210.8000 to $211.7800.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13535.2377,"source":{"system":"sec-edgar","filing":"0001225208-19-010542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819010542/doc4.xml","form_type":"4"}},{"id":3455478,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-07-27T00:03:54.000Z","date":"2019-07-25","kind":"sale","acquired":false,"shares":4800,"price":212.2994,"value":1019037.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $211.8100 to $212.5500.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18527.2377,"source":{"system":"sec-edgar","filing":"0001225208-19-010542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819010542/doc4.xml","form_type":"4"}},{"id":3455477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-07-27T00:03:54.000Z","date":"2019-07-25","kind":"sale","acquired":false,"shares":4625,"price":209.9858,"value":971184.325,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $209.7850 to $210.1900.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23327.2377,"source":{"system":"sec-edgar","filing":"0001225208-19-010542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819010542/doc4.xml","form_type":"4"}},{"id":3455476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-07-27T00:03:54.000Z","date":"2019-07-25","kind":"sale","acquired":false,"shares":3000,"price":213.1208,"value":639362.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $213.0300 to $213.3300.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27952.2377,"source":{"system":"sec-edgar","filing":"0001225208-19-010542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819010542/doc4.xml","form_type":"4"}},{"id":3455475,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-07-27T00:03:54.000Z","date":"2019-07-25","kind":"exercise","acquired":true,"shares":7297,"price":35.785,"value":261123.145,"ownership":{"direct":true},"balance_after":30952.2377,"source":{"system":"sec-edgar","filing":"0001225208-19-010542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819010542/doc4.xml","form_type":"4"}},{"id":3455474,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-07-27T00:03:54.000Z","date":"2019-07-25","kind":"exercise","acquired":true,"shares":10120,"price":41.94,"value":424432.8,"ownership":{"direct":true},"balance_after":23655.2377,"source":{"system":"sec-edgar","filing":"0001225208-19-010542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819010542/doc4.xml","form_type":"4"}},{"id":3528201,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-05-14T23:04:19.000Z","date":"2019-05-14","kind":"tax_withholding","acquired":false,"shares":143,"price":178.17,"value":25478.31,"ownership":{"direct":true},"balance_after":13446.9846,"source":{"system":"sec-edgar","filing":"0001225208-19-007995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819007995/doc4.xml","form_type":"4"}},{"id":3528200,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-05-14T23:04:19.000Z","date":"2019-05-12","kind":"tax_withholding","acquired":false,"shares":85,"price":181.1,"value":15393.5,"ownership":{"direct":true},"balance_after":13589.9846,"source":{"system":"sec-edgar","filing":"0001225208-19-007995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819007995/doc4.xml","form_type":"4"}},{"id":3532132,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Controller (Principa"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2019-05-10T20:25:49.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":2410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":2410,"derivative":{"exercise_price":177.77,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":2410},"source":{"system":"sec-edgar","filing":"0001223203-19-000029","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122320319000029/primary_doc.xml","form_type":"4"}},{"id":3532131,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Controller (Principa"}}],"security":"Common Stock","published_at":"2019-05-10T20:25:49.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date."}],"balance_after":13674.9846,"source":{"system":"sec-edgar","filing":"0001223203-19-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122320319000029/primary_doc.xml","form_type":"4"}},{"id":3547981,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2019-04-26T23:06:58.000Z","date":"2019-04-26","kind":"exercise","acquired":false,"shares":821,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":42.725,"exercise_date":"2013-05-09","expiration_date":"2019-05-08","underlying":"Common Stock","underlying_shares":821},"source":{"system":"sec-edgar","filing":"0001225208-19-007240","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819007240/doc4.xml","form_type":"4"}},{"id":3547980,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-04-26T23:06:58.000Z","date":"2019-04-26","kind":"sale","acquired":false,"shares":821,"price":175.36,"value":143970.56,"ownership":{"direct":true},"balance_after":13354.9846,"source":{"system":"sec-edgar","filing":"0001225208-19-007240","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819007240/doc4.xml","form_type":"4"}},{"id":3547979,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-04-26T23:06:58.000Z","date":"2019-04-26","kind":"exercise","acquired":true,"shares":821,"price":42.725,"value":35077.225,"ownership":{"direct":true},"balance_after":14175.9846,"source":{"system":"sec-edgar","filing":"0001225208-19-007240","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819007240/doc4.xml","form_type":"4"}},{"id":3639550,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2019-02-23T00:09:30.000Z","date":"2019-02-22","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7297,"derivative":{"exercise_price":35.785,"exercise_date":"2014-05-14","expiration_date":"2020-05-13","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001225208-19-003457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819003457/doc4.xml","form_type":"4"}},{"id":3639549,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-02-23T00:09:30.000Z","date":"2019-02-22","kind":"sale","acquired":false,"shares":500,"price":175.0387,"value":87519.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $175.03 to $175.07.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13281.5648,"source":{"system":"sec-edgar","filing":"0001225208-19-003457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819003457/doc4.xml","form_type":"4"}},{"id":3639548,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-02-23T00:09:30.000Z","date":"2019-02-22","kind":"exercise","acquired":true,"shares":500,"price":35.785,"value":17892.5,"ownership":{"direct":true},"balance_after":13781.5648,"source":{"system":"sec-edgar","filing":"0001225208-19-003457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819003457/doc4.xml","form_type":"4"}},{"id":3642839,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2019-02-22T02:39:05.000Z","date":"2019-02-21","kind":"exercise","acquired":false,"shares":2623,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7797,"derivative":{"exercise_price":35.785,"exercise_date":"2014-05-14","expiration_date":"2020-05-13","underlying":"Common Stock","underlying_shares":2623},"source":{"system":"sec-edgar","filing":"0001225208-19-003317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819003317/doc4.xml","form_type":"4"}},{"id":3642838,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-02-22T02:39:05.000Z","date":"2019-02-21","kind":"sale","acquired":false,"shares":2623,"price":175.0756,"value":459223.2988,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $175.03 to $175.12.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13281.5648,"source":{"system":"sec-edgar","filing":"0001225208-19-003317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819003317/doc4.xml","form_type":"4"}},{"id":3642837,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-02-22T02:39:05.000Z","date":"2019-02-21","kind":"exercise","acquired":true,"shares":2623,"price":35.785,"value":93864.055,"ownership":{"direct":true},"balance_after":15904.5648,"source":{"system":"sec-edgar","filing":"0001225208-19-003317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520819003317/doc4.xml","form_type":"4"}},{"id":3753870,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2018-11-23T22:31:14.000Z","date":"2018-11-21","kind":"exercise","acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":821,"derivative":{"exercise_price":42.725,"exercise_date":"2013-05-09","expiration_date":"2019-05-08","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001225208-18-015843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818015843/doc4.xml","form_type":"4"}},{"id":3753869,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2018-11-23T22:31:14.000Z","date":"2018-11-20","kind":"exercise","acquired":false,"shares":5259,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3421,"derivative":{"exercise_price":42.725,"exercise_date":"2013-05-09","expiration_date":"2019-05-08","underlying":"Common Stock","underlying_shares":5259},"source":{"system":"sec-edgar","filing":"0001225208-18-015843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818015843/doc4.xml","form_type":"4"}},{"id":3753868,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-11-23T22:31:14.000Z","date":"2018-11-21","kind":"sale","acquired":false,"shares":2600,"price":153.1821,"value":398273.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $153.00 to $153.48.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13281.5648,"source":{"system":"sec-edgar","filing":"0001225208-18-015843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818015843/doc4.xml","form_type":"4"}},{"id":3753867,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-11-23T22:31:14.000Z","date":"2018-11-21","kind":"exercise","acquired":true,"shares":2600,"price":42.725,"value":111085.0,"ownership":{"direct":true},"balance_after":15881.5648,"source":{"system":"sec-edgar","filing":"0001225208-18-015843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818015843/doc4.xml","form_type":"4"}},{"id":3753866,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-11-23T22:31:14.000Z","date":"2018-11-20","kind":"sale","acquired":false,"shares":5259,"price":153.1441,"value":805384.8219,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $153.00 to $153.37.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13281.5648,"source":{"system":"sec-edgar","filing":"0001225208-18-015843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818015843/doc4.xml","form_type":"4"}},{"id":3753865,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-11-23T22:31:14.000Z","date":"2018-11-20","kind":"exercise","acquired":true,"shares":5259,"price":42.725,"value":224690.775,"ownership":{"direct":true},"balance_after":18540.5648,"source":{"system":"sec-edgar","filing":"0001225208-18-015843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818015843/doc4.xml","form_type":"4"}},{"id":3924496,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2018-05-22T00:48:03.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":3070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":3070,"derivative":{"exercise_price":135.83,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":3070},"source":{"system":"sec-edgar","filing":"0001225208-18-009682","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818009682/doc4.xml","form_type":"4"}},{"id":3924495,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-05-22T00:48:03.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date."}],"balance_after":13161.3091,"source":{"system":"sec-edgar","filing":"0001225208-18-009682","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818009682/doc4.xml","form_type":"4"}},{"id":3931386,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-05-17T00:55:31.000Z","date":"2018-05-14","kind":"tax_withholding","acquired":false,"shares":201,"price":138.11,"value":27760.11,"ownership":{"direct":true},"balance_after":12741.3091,"source":{"system":"sec-edgar","filing":"0001225208-18-009499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818009499/doc4.xml","form_type":"4"}},{"id":3939548,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-05-10T22:49:11.000Z","date":"2018-05-08","kind":"tax_withholding","acquired":false,"shares":238,"price":136.09,"value":32389.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator."}],"balance_after":12942.3091,"source":{"system":"sec-edgar","filing":"0001225208-18-009118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818009118/doc4.xml","form_type":"4"}},{"id":4074316,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2018-02-07T02:40:50.000Z","date":"2018-02-05","kind":"exercise","acquired":false,"shares":8120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":44.615,"exercise_date":"2012-05-12","expiration_date":"2018-05-11","underlying":"Common Stock","underlying_shares":8120},"source":{"system":"sec-edgar","filing":"0001225208-18-002197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818002197/doc4.xml","form_type":"4"}},{"id":4074315,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-02-07T02:40:50.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":5657,"price":130.5831,"value":738708.5967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $130.03 to $130.99.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":13092.5514,"source":{"system":"sec-edgar","filing":"0001225208-18-002197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818002197/doc4.xml","form_type":"4"}},{"id":4074314,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-02-07T02:40:50.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":2500,"price":131.6638,"value":329159.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $131.34 to $132.05.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18749.5514,"source":{"system":"sec-edgar","filing":"0001225208-18-002197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818002197/doc4.xml","form_type":"4"}},{"id":4074313,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-02-07T02:40:50.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":2463,"price":131.4663,"value":323801.4969,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $131.14 to $131.8050.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21249.5514,"source":{"system":"sec-edgar","filing":"0001225208-18-002197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818002197/doc4.xml","form_type":"4"}},{"id":4074312,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-02-07T02:40:50.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":1400,"price":130.9036,"value":183265.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $130.32 to $131.31.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23712.5514,"source":{"system":"sec-edgar","filing":"0001225208-18-002197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818002197/doc4.xml","form_type":"4"}},{"id":4074311,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-02-07T02:40:50.000Z","date":"2018-02-05","kind":"exercise","acquired":true,"shares":8120,"price":44.615,"value":362273.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator."}],"balance_after":25112.5514,"source":{"system":"sec-edgar","filing":"0001225208-18-002197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818002197/doc4.xml","form_type":"4"}},{"id":4316477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2017-05-17T21:04:39.000Z","date":"2017-05-15","kind":"tax_withholding","acquired":false,"shares":322,"price":110.59,"value":35609.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":16852.3757,"source":{"system":"sec-edgar","filing":"0001225208-17-009993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009993/doc4.xml","form_type":"4"}},{"id":4321439,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-05-15T21:20:22.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":4070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on May 11, 2017 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":4070,"derivative":{"exercise_price":110.25,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":4070},"source":{"system":"sec-edgar","filing":"0001225208-17-009783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009783/doc4.xml","form_type":"4"}},{"id":4321438,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2017-05-15T21:20:22.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 11, 2017 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":17174.3757,"source":{"system":"sec-edgar","filing":"0001225208-17-009783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009783/doc4.xml","form_type":"4"}},{"id":4328812,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2017-05-10T01:19:41.000Z","date":"2017-05-08","kind":"tax_withholding","acquired":false,"shares":311,"price":110.58,"value":34390.38,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":16629.3757,"source":{"system":"sec-edgar","filing":"0001225208-17-009438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009438/doc4.xml","form_type":"4"}},{"id":4342473,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-04-28T21:11:54.000Z","date":"2017-04-27","kind":"exercise","acquired":false,"shares":12960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":25.48,"exercise_date":"2011-05-13","expiration_date":"2017-05-12","underlying":"Common Stock","underlying_shares":12960},"source":{"system":"sec-edgar","filing":"0001225208-17-008605","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817008605/doc4.xml","form_type":"4"}},{"id":4342472,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2017-04-28T21:11:54.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":12960,"price":109.5,"value":1419120.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.  This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator."}],"balance_after":16940.3757,"source":{"system":"sec-edgar","filing":"0001225208-17-008605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817008605/doc4.xml","form_type":"4"}},{"id":4342471,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":91186,"kind":"person","name":"SELLERS ROBERT W.A.","position":1,"cik":"0001600739","reported_name":"SELLERS ROBERT W.A.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2017-04-28T21:11:54.000Z","date":"2017-04-27","kind":"exercise","acquired":true,"shares":12960,"price":25.48,"value":330220.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.  This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator."}],"balance_after":29900.3757,"source":{"system":"sec-edgar","filing":"0001225208-17-008605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817008605/doc4.xml","form_type":"4"}}]}